In one paragraphArticle in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Yerbol BulatovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-8543-4219 Nurlan KozhabergenovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-6299-9399 Zhanat AmanovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-3987-6814 Zhanna SametovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-2332-2841 Zhanat KondybaevaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-8224-8047 Ruslan AbitayevResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-5609-2491 Abdurakhman UssembayResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0003-3639-3793 Alina KurmashevaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0009-0008-9484-0540 Dariya ToktyrovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0003-3166-4515 Dana MazbayevaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0009-0002-3892-0032 Kuandyk ZhugunissovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0003-4238-5116 Muratbay MambetaliyevResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-6034-6642 Bekbolat UsserbayevResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-4615-1328 Sholpan TuryskeldyResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-9515-0655 Funding
Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan AP19676030
6 · The paper itselfAbstract
This study continues earlier work aimed at identifying potential natural reservoirs of camelpox virus (CMLV) during interepizootic periods. In 2023-2024, field expeditions in western Kazakhstan led to the collection and analysis of biological samples from camels, rodents and hematophagous insects. Despite the absence of clinical symptoms, PCR-positive results were obtained from camel blood samples. These samples underwent molecular genetic analysis, including viral DNA detection and whole-genome sequencing. Using next-generation sequencing, the complete genome of the
Indexed as
CamelusOrthopoxvirusPhylogenyPoxviridae InfectionsAnimalsDisease ReservoirsDNA, ViralGenome, ViralHigh-Throughput Nucleotide SequencingKazakhstanWhole Genome SequencingDNA, ViralCamelpox virusisolateOrthopoxvirusphylogenetic analysisreservoirs
Identifiers
PMID41012657
PMCPMC12474500
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390